Capitol Fax.com - Your Illinois News Radar


Latest Post | Last 10 Posts | Archives


Previous Post: *** UPDATED *** Question of the day: Pritzker signs revised remap bill
Next Post: Reader comments closed for the weekend

IDPH adopts CDC booster shot recommendation

Posted in:

* Press release…

The Illinois Department of Public Health (IDPH) is adopting the Centers for Disease Control and Prevention’s (CDC) recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in certain populations and a booster dose for those in high risk occupational and institutional settings.

CDC recommends the following groups should receive boosters:

Additionally, CDC recommends the following groups may be considered for boosters.

“While the vaccines continue to be highly effective at preventing severe illnesses, hospitalization, death, as we learn more about COVID-19 and the science evolves, so too must our recommendations,” said IDPH Director Dr. Ngozi Ezike. “Scientists and medical experts continue to monitor vaccines for waning immunity and how well the vaccines protect against new variants, and across which age groups and risk factors. The information reviewed by the FDA shows that there is clear evidence of the benefit of booster doses at this time.”

IDPH recommends vaccine providers prioritize those at highest risk of severe illness among the eligible booster population.
Many of the people who are now eligible to receive a booster shot received their initial vaccine early in the rollout and will benefit from additional protection. The Delta variant continues to be the predominate virus circulating and with cases of COVID-19 increasing significantly across the United States, a booster shot will help strengthen protection against severe disease in those populations who are at high-risk for exposure to COVID-19 or the complications from severe disease.
Individuals may contact their health care provider or visit www.vaccines.gov to find a nearby location to receive a booster dose.

Right now, only the Pfizer-BioNTech vaccine is authorized for booster doses in recommended populations. The U.S. Food and Drug Administration has given full approval for Pfizer-BioNTech, marketed as Comirnaty, for those ages 16 years and older. The Pfizer-BioNTech and Comirnaty COVID-19 vaccines are the same vaccine.

Data is expected to be submitted soon to the U.S. Food and Drug Administration on the safety and efficacy of booster doses for Moderna and Johnson & Johnson vaccines for further recommendations on booster doses.

posted by Rich Miller
Friday, Sep 24, 21 @ 3:53 pm

Comments

  1. I know what I’ll be doing this weekend

    Comment by Rich Miller Friday, Sep 24, 21 @ 3:53 pm

  2. Great news, looking forward to getting a booster when I qualify

    Comment by Oswego Willy Friday, Sep 24, 21 @ 3:58 pm

  3. Going in Tuesday.

    Comment by Back to the Future Friday, Sep 24, 21 @ 3:59 pm

  4. Debating on whether my underlying condition is enough reason to get a booster. I think hypertension qualifies me.

    Comment by Demoralized Friday, Sep 24, 21 @ 4:03 pm

  5. bugging my doc……

    Comment by Amalia Friday, Sep 24, 21 @ 4:15 pm

  6. Wondering if my asthma qualifies me for a booster or if I need to wait 8 months until I turn 65. Hmmmm

    Comment by Manchester Friday, Sep 24, 21 @ 4:24 pm

  7. ==Debating on whether my underlying condition is enough reason to get a booster. I think hypertension qualifies me.==

    I’m pretty certain my underlying (high blood pressure and on meds) might make it a good idea to get the booster. Planning to get it before Thanksgiving (although my second shot was early April).

    Comment by NonAFSCMEStateEmployeeFromChatham Friday, Sep 24, 21 @ 4:25 pm

Add a comment

Sorry, comments are closed at this time.

Previous Post: *** UPDATED *** Question of the day: Pritzker signs revised remap bill
Next Post: Reader comments closed for the weekend


Last 10 posts:

more Posts (Archives)

WordPress Mobile Edition available at alexking.org.

powered by WordPress.